Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Ischaemic pain
- Focus Therapeutic Use
- 13 Jun 2018 Status changed from recruiting to discontinued.
- 07 May 2015 Planned End Date changed from 1 Jul 2009 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 07 May 2015 Planned primary completion date changed from 1 Jun 2009 to 1 May 2015 as reported by ClinicalTrials.gov record.